Vitamin D deficiency can lead to osteomalacia, a rare bone disorder that causes bone pain and muscle weakness. But taking too ...

Hypercalcemia affects up to 30% of patients with cancer. 1 It has been seen in most cancers but is most common in patients with non-small cell lung cancer, breast cancer, multiple myeloma, head and ...

Hypercalcemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer, and is associated with a high degree of morbidity and mortality. It affects an estimated 2%–30 ...

HYPERCALCEMIA is a clinical finding that is usually controlled by relatively simple procedures but occasionally presents an acute medical emergency. It occurs in a wide variety of disorders such as ...

Sometimes a supplement meant to support better health can push the body in the opposite direction, creating physical changes ...

HYPERCALCEMIA occurs in a wide variety of diseases (for example, hyperparathyroidism, hypervitaminosis D, sarcoid, cancer, hyperthyroidism and poliomyelitis) 1 and is often responsible for many of the ...

The authors used Ovid Medline to search for human trials on hypercalcemia and furosemide from 1950 to April 2008, and articles related to bisphosphonates and hypercalcemia during the same period.

Multiple myeloma is a plasma-cell cancer causing bone destruction, anaemia, recurrent infections, renal dysfunction, and hypercalcemia. It presents with bone pain, fractures, fatigue, weight loss, and ...

PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from severe tophaceous gout, according to a case study presented at the ASN Kidney Week. The case ...